Related Experiment Video
Updated: Jun 21, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
Differential regulation of Apak by various DNA damage signals
Shan Wang1, Chunyan Tian, Tingting Xiao
1College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&F University, 712100, Yangling, Shaanxi, China.
Abstract:
The tumor suppressor p53 lies at the center of a protein-signaling network that responds to many types of stress, and p53 activation leads to cell cycle arrest or apoptosis. We recently identified ATM and p53-associated KZNF protein (Apak) as a negative regulator of p53-mediated apoptosis. After treatment of cells with methyl methanesulfonate (MMS), Apak is phosphorylated by ATM kinase and dissociates from p53, resulting in p53 activation and induction of apoptosis. However, the mechanism by which Apak is regulated in response to other types of DNA damage signals remains unclear. Here, we show that four of seven types of DNA damage signals we examined (induction by etoposide, doxorubicin, camptothecin and cisplatin treatment) resulted in significant Apak phosphorylation and dissociation of Apak from p53, releasing the inhibition of p53 transcriptional activity. In contrast, Apak was not phosphorylated at Ser68 after 5-fluorouracil or alpha-lipoic acid treatment and persistently inhibited p53 activity. These findings provide evidence that the Apak-p53 interaction is regulated differentially by various DNA damage signals.
Insights
The ATM and p53-associated KZNF protein (Apak) regulates p53-mediated apoptosis. Different DNA damage signals differentially regulate Apak phosphorylation, impacting its interaction with p53 and subsequent apoptosis.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Cancer Research
Background:
- The tumor suppressor p53 is central to cellular stress response, mediating cell cycle arrest or apoptosis.
- ATM and p53-associated KZNF protein (Apak) was identified as a negative regulator of p53-mediated apoptosis.
- Apak phosphorylation by ATM kinase leads to p53 activation following methyl methanesulfonate (MMS) treatment.
Purpose of the Study:
- To investigate the regulation of Apak in response to diverse DNA damage signals.
- To elucidate the differential mechanisms of Apak-p53 interaction modulation by various genotoxic agents.
Main Methods:
- Cell treatment with various DNA damaging agents (etoposide, doxorubicin, camptothecin, cisplatin, 5-fluorouracil, alpha-lipoic acid).
- Analysis of Apak phosphorylation status (specifically at Ser68).
- Assessment of Apak-p53 complex dissociation and p53 transcriptional activity.
Main Results:
- Four out of seven DNA damage signals induced Apak phosphorylation and dissociation from p53, releasing p53 inhibition.
- Etoposide, doxorubicin, camptothecin, and cisplatin treatments resulted in Apak phosphorylation and p53 activation.
- 5-fluorouracil and alpha-lipoic acid treatments did not induce Apak phosphorylation, leading to persistent p53 inhibition.
Conclusions:
- The Apak-p53 interaction is subject to differential regulation by distinct DNA damage signals.
- Apak acts as a crucial checkpoint, with its phosphorylation status determining p53's apoptotic or cell cycle arrest function.
- Understanding these differential regulations could offer new therapeutic strategies targeting p53 pathways in cancer.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Regulation of the Unfolded Protein Response

